Association of systemic lupus erythematosus with low serum bilirubin levels

References

• Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008;358:929–39.
   PubMed Web of Science ®Google Scholar
• Mansour RB, Lassoued S, Gargouri B, El Gaid A, Attia H, Fakhfakh F. Increased levels of autoantibodies against catalase and superoxide dismutase associated with oxidative stress in patients with rheumatoid arthritis and systemic lupus erythematosus. Scand J Rheumatol 2008;37:103–8.
   PubMed Web of Science ®Google Scholar
• Scalzi LV, Ballou SP, Park JY, Redline S, Kirchner HL. Cardiovascular disease risk awareness in systemic lupus erythematosus patients. Arthritis Rheum 2008;58:1458–64.
   PubMedGoogle Scholar
• Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987;235:1043–6.
   PubMed Web of Science ®Google Scholar
• Belanger S, Lavoie JC, Chessex P. Influence of bilirubin on the antioxidant capacity of plasma in newborn infants. Biol Neonate 1997;71:233–8.
   PubMedGoogle Scholar
• Vítek L, Malikova I, Kvasnicka J, Benakova H, Novotny L. Relationship between serum bilirubin and markers of inflammation and oxidative stress. J Gastroenterol Hepatol 2007;22:A235.
   Google Scholar
• Vítek L, Jirsa M, Brodanova M, Kalab M, Marecek Z, Danzig V, Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 2002;160:449–56.
   PubMed Web of Science ®Google Scholar
• Ilzecka J, Stelmasiak Z. Serum bilirubin concentration in patients with amyotrophic lateral sclerosis. Clin Neurol Neurosurg 2003;105:237–40.
   PubMedGoogle Scholar
• Nuttall SL, Heaton S, Piper MK, Martin U, Gordon C. Cardiovascular risk in systemic lupus erythematosus – evidence of increased oxidative stress and dyslipidaemia. Rheumatology 2003;42:758–62.
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–7.
   PubMed Web of Science ®Google Scholar
• Delgado AJ, Ames PR, Donohue S, Stanyer L, Nourooz-Zadeh J, Ravirajan C, Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome. Arthritis Rheum 2002;46:2686–94.
   PubMedGoogle Scholar
• Vítek L, Schwertner HA. The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv Clin Chem 2007;43:1–57.
   PubMed Web of Science ®Google Scholar
• Breimer LH, Wannamethee G, Ebrahim S, Shaper AG. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem 1995;41:1504–8.
   PubMed Web of Science ®Google Scholar
• Horwitz DA. Regulatory T cells in systemic lupus erythematosus: past, present and future. Arthritis Res Ther 2008;10:227.
   PubMedGoogle Scholar
• Phelan D, Winter GM, Rogers WJ, Lam JC, Denison MS. Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin. Arch Biochem Biophys 1998;357:155–63.
   PubMed Web of Science ®Google Scholar
• Stevens EA, Bradfield CA. Immunology: T cells hang in the balance. Nature 2008;453:46–7.
   PubMedGoogle Scholar
• Lei W, Luo Y, Yan K, Zhao S, Li Y, Qiu X, Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009:38;369–74.
   PubMed Web of Science ®Google Scholar
• Lanone S, Bloc S, Foresti R, Almolki A, Taille C, Callebert J, Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FASEB J 2005;19:1890–2.
   PubMed Web of Science ®Google Scholar
• Olsson LM, Lindqvist AK, Kallberg H, Padyukov L, Burkhadt H, Alfredsson L, A case–control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity. Arthritis Res Ther 2007;9:R98.
   PubMedGoogle Scholar
• Keshavan P, Deem TL, Schwemberger SJ, Babcock GF, Cook-Mills JM, Zucker SD. Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. J Immunol 2005;174:3709–18.
   PubMed Web of Science ®Google Scholar
• Lewis MJ, D’Cruz D. Adhesion molecules, mycophenolate mofetil and systemic lupus erythematosus. Lupus 2005;14(Suppl 1):s17–26.
   PubMedGoogle Scholar
• Zucker SD, Horn PS, Sherman KE. Serum bilirubin levels in the US population: gender effect and inverse correlation with colorectal cancer. Hepatology 2004;40:827–35.
   PubMed Web of Science ®Google Scholar
• Schwertner HA. Association of smoking and low serum bilirubin antioxidant concentrations. Atherosclerosis 1998;136:383–7.
   PubMed Web of Science ®Google Scholar
• Van H, Temme EH, Schouten EG. Serum bilirubin concentration in a Belgian population: the association with smoking status and type of cigarettes. Int J Epidemiol 2001;30:1465–72.
   PubMedGoogle Scholar